Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients

NCT01404325 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Transplantation

Interventions

DRUG: standard therapy
DRUG: Everolimus

Sponsor

Novartis Pharmaceuticals